Immunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring antitumor immunity.

Radhakrishnan S, Nguyen LT, Ciric B, Flies D, Van Keulen VP, Tamada K, Chen L, Rodriguez M, Pease LR

Open source

DOI
10.1158/0008-5472.can-03-3025
Published
2004 Jul 15
Container
Cancer research
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/0008-5472.can-03-3025,
  title = {Immunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring antitumor immunity.},
  author = {Radhakrishnan S and Nguyen LT and Ciric B and Flies D and Van Keulen VP and Tamada K and Chen L and Rodriguez M and Pease LR},
  year = {2004},
  journal = {Cancer research},
  doi = {10.1158/0008-5472.can-03-3025},
  url = {https://doi.org/10.1158/0008-5472.can-03-3025}
}

RIS

TY  - JOUR
TI  - Immunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring antitumor immunity.
AU  - Radhakrishnan S
AU  - Nguyen LT
AU  - Ciric B
AU  - Flies D
AU  - Van Keulen VP
AU  - Tamada K
AU  - Chen L
AU  - Rodriguez M
AU  - Pease LR
PY  - 2004
JO  - Cancer research
DO  - 10.1158/0008-5472.can-03-3025
UR  - https://doi.org/10.1158/0008-5472.can-03-3025
ER  - 

APA

S, R., LT, N., B, C., D, F., VP, V. K., K, T., L, C., M, R., & LR, P. (2004). Immunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring antitumor immunity.. Cancer research. https://doi.org/10.1158/0008-5472.can-03-3025

Source records